Cargando…
Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin
Recent data suggest that olfactory deficits could represent an early marker and a pathogenic mechanism at the basis of cognitive decline in type 2 diabetes (T2D). However, research is needed to further characterize olfactory deficits in diabetes, their relation to cognitive decline and underlying me...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824492/ https://www.ncbi.nlm.nih.gov/pubmed/29471869 http://dx.doi.org/10.1186/s40478-018-0517-1 |
_version_ | 1783302035436732416 |
---|---|
author | Lietzau, Grazyna Davidsson, William Östenson, Claes-Göran Chiazza, Fausto Nathanson, David Pintana, Hiranya Skogsberg, Josefin Klein, Thomas Nyström, Thomas Darsalia, Vladimer Patrone, Cesare |
author_facet | Lietzau, Grazyna Davidsson, William Östenson, Claes-Göran Chiazza, Fausto Nathanson, David Pintana, Hiranya Skogsberg, Josefin Klein, Thomas Nyström, Thomas Darsalia, Vladimer Patrone, Cesare |
author_sort | Lietzau, Grazyna |
collection | PubMed |
description | Recent data suggest that olfactory deficits could represent an early marker and a pathogenic mechanism at the basis of cognitive decline in type 2 diabetes (T2D). However, research is needed to further characterize olfactory deficits in diabetes, their relation to cognitive decline and underlying mechanisms. The aim of this study was to determine whether T2D impairs odour detection, olfactory memory as well as neuroplasticity in two major brain areas responsible for olfaction and odour coding: the main olfactory bulb (MOB) and the piriform cortex (PC), respectively. Dipeptidyl peptidase-4 inhibitors (DPP-4i) are clinically used T2D drugs exerting also beneficial effects in the brain. Therefore, we aimed to determine whether DPP-4i could reverse the potentially detrimental effects of T2D on the olfactory system. Non-diabetic Wistar and T2D Goto-Kakizaki rats, untreated or treated for 16 weeks with the DPP-4i linagliptin, were employed. Odour detection and olfactory memory were assessed by using the block, the habituation-dishabituation and the buried pellet tests. We assessed neuroplasticity in the MOB by quantifying adult neurogenesis and GABAergic inhibitory interneurons positive for calbindin, parvalbumin and carletinin. In the PC, neuroplasticity was assessed by quantifying the same populations of interneurons and a newly identified form of olfactory neuroplasticity mediated by post-mitotic doublecortin (DCX) + immature neurons. We show that T2D dramatically reduced odour detection and olfactory memory. Moreover, T2D decreased neurogenesis in the MOB, impaired the differentiation of DCX+ immature neurons in the PC and altered GABAergic interneurons protein expression in both olfactory areas. DPP-4i did not improve odour detection and olfactory memory. However, it normalized T2D-induced effects on neuroplasticity. The results provide new knowledge on the detrimental effects of T2D on the olfactory system. This knowledge could constitute essentials for understanding the interplay between T2D and cognitive decline and for designing effective preventive therapies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-018-0517-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5824492 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58244922018-02-26 Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin Lietzau, Grazyna Davidsson, William Östenson, Claes-Göran Chiazza, Fausto Nathanson, David Pintana, Hiranya Skogsberg, Josefin Klein, Thomas Nyström, Thomas Darsalia, Vladimer Patrone, Cesare Acta Neuropathol Commun Research Recent data suggest that olfactory deficits could represent an early marker and a pathogenic mechanism at the basis of cognitive decline in type 2 diabetes (T2D). However, research is needed to further characterize olfactory deficits in diabetes, their relation to cognitive decline and underlying mechanisms. The aim of this study was to determine whether T2D impairs odour detection, olfactory memory as well as neuroplasticity in two major brain areas responsible for olfaction and odour coding: the main olfactory bulb (MOB) and the piriform cortex (PC), respectively. Dipeptidyl peptidase-4 inhibitors (DPP-4i) are clinically used T2D drugs exerting also beneficial effects in the brain. Therefore, we aimed to determine whether DPP-4i could reverse the potentially detrimental effects of T2D on the olfactory system. Non-diabetic Wistar and T2D Goto-Kakizaki rats, untreated or treated for 16 weeks with the DPP-4i linagliptin, were employed. Odour detection and olfactory memory were assessed by using the block, the habituation-dishabituation and the buried pellet tests. We assessed neuroplasticity in the MOB by quantifying adult neurogenesis and GABAergic inhibitory interneurons positive for calbindin, parvalbumin and carletinin. In the PC, neuroplasticity was assessed by quantifying the same populations of interneurons and a newly identified form of olfactory neuroplasticity mediated by post-mitotic doublecortin (DCX) + immature neurons. We show that T2D dramatically reduced odour detection and olfactory memory. Moreover, T2D decreased neurogenesis in the MOB, impaired the differentiation of DCX+ immature neurons in the PC and altered GABAergic interneurons protein expression in both olfactory areas. DPP-4i did not improve odour detection and olfactory memory. However, it normalized T2D-induced effects on neuroplasticity. The results provide new knowledge on the detrimental effects of T2D on the olfactory system. This knowledge could constitute essentials for understanding the interplay between T2D and cognitive decline and for designing effective preventive therapies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-018-0517-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-23 /pmc/articles/PMC5824492/ /pubmed/29471869 http://dx.doi.org/10.1186/s40478-018-0517-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lietzau, Grazyna Davidsson, William Östenson, Claes-Göran Chiazza, Fausto Nathanson, David Pintana, Hiranya Skogsberg, Josefin Klein, Thomas Nyström, Thomas Darsalia, Vladimer Patrone, Cesare Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin |
title | Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin |
title_full | Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin |
title_fullStr | Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin |
title_full_unstemmed | Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin |
title_short | Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin |
title_sort | type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the dpp-4 inhibitor linagliptin |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824492/ https://www.ncbi.nlm.nih.gov/pubmed/29471869 http://dx.doi.org/10.1186/s40478-018-0517-1 |
work_keys_str_mv | AT lietzaugrazyna type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT davidssonwilliam type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT ostensonclaesgoran type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT chiazzafausto type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT nathansondavid type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT pintanahiranya type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT skogsbergjosefin type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT kleinthomas type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT nystromthomas type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT darsaliavladimer type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin AT patronecesare type2diabetesimpairsodourdetectionolfactorymemoryandolfactoryneuroplasticityeffectspartlyreversedbythedpp4inhibitorlinagliptin |